PortfoliosLab logoPortfoliosLab logo
PPH vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PPH vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Vectors Pharmaceutical ETF (PPH) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


PPH

1D
0.33%
1M
-0.56%
YTD
-0.76%
6M
2.14%
1Y
17.87%
3Y*
12.03%
5Y*
9.22%
10Y*
7.46%

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PPH vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
PPH
VanEck Vectors Pharmaceutical ETF
-0.76%22.00%-9.93%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

PPH vs. GERM - Sectors Allocation Comparison


Sectors
PPH
GERM

Healthcare

100.0%
99.3%

Industrials

0.1%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

0.4%

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

PPH
100.0%
GERM
99.3%

Industrials

PPH
0.1%
GERM

-

Basic Materials

PPH

-

GERM

-

Communication Services

PPH

-

GERM

-

Consumer Cyclical

PPH

-

GERM

-

Consumer Defensive

PPH

-

GERM

-

Energy

PPH

-

GERM

-

Financial Services

PPH

-

GERM
0.4%

Real Estate

PPH

-

GERM

-

Technology

PPH

-

GERM

-

Utilities

PPH

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PPH vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PPH
PPH Risk / Return Rank: 2929
Overall Rank
PPH Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
PPH Sortino Ratio Rank: 3030
Sortino Ratio Rank
PPH Omega Ratio Rank: 2828
Omega Ratio Rank
PPH Calmar Ratio Rank: 3333
Calmar Ratio Rank
PPH Martin Ratio Rank: 2727
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PPH vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PPHGERMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.19

Calmar ratioReturn relative to maximum drawdown

1.67

Martin ratioReturn relative to average drawdown

3.88

PPH vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


PPHGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.04

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.61

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

Sharpe Ratio (All Time)

Calculated using the full available price history

0.30

Drawdowns

PPH vs. GERM - Drawdown Comparison

The maximum PPH drawdown since its inception was -51.45%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PPH and GERM.


Loading charts...

Drawdown Indicators


PPHGERMDifference

Max Drawdown

Largest peak-to-trough decline

-51.45%

0.00%

-51.45%

Max Drawdown (1Y)

Largest decline over 1 year

-10.76%

0.00%

-10.76%

Max Drawdown (3Y)

Largest decline over 3 years

-18.06%

Max Drawdown (5Y)

Largest decline over 5 years

-20.26%

Max Drawdown (10Y)

Largest decline over 10 years

-29.70%

Current Drawdown

Current decline from peak

-8.34%

0.00%

-8.34%

Average Drawdown

Average peak-to-trough decline

-17.31%

0.00%

-17.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.61%

0.00%

+4.61%

Volatility

PPH vs. GERM - Volatility Comparison

VanEck Vectors Pharmaceutical ETF (PPH) has a higher volatility of 4.73% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that PPH's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PPHGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.73%

0.00%

+4.73%

Volatility (6M)

Calculated over the trailing 6-month period

11.67%

0.00%

+11.67%

Volatility (1Y)

Calculated over the trailing 1-year period

17.26%

0.00%

+17.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

15.07%

0.00%

+15.07%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.96%

0.00%

+16.96%

PPH vs. GERM - Expense Ratio Comparison

PPH has a 0.36% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

PPH vs. GERM - Dividend Comparison

PPH's dividend yield for the trailing twelve months is around 2.12%, while GERM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PPH
VanEck Vectors Pharmaceutical ETF
2.12%1.78%1.98%2.09%1.55%1.62%1.66%1.77%1.97%1.92%2.43%1.93%

Frequently Asked Questions


PPH has higher volatility (4.73%) compared to GERM (0.00%). In terms of maximum drawdown, PPH dropped -51.45% vs GERM's 0.00%.

On 1-year performance, PPH leads with 17.87% vs 0.00% for GERM. On fees, PPH is cheaper at 0.36% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, PPH has performed better with a 17.87% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

PPH is cheaper with a 0.36% expense ratio, compared with 0.68% for GERM.

PPH has the higher dividend yield at 2.12%, compared with 0.00% for GERM.

PPH tracks MVIS US Listed Pharmaceutical 25 Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: VanEck and Amplify. Their fees differ too: 0.36% for PPH and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for PPH and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer